Entrada Therapeutics, Inc. (TRDA)
Largest Insider Buys in Sector
TRDA Stock Price History Chart
TRDA Stock Performance
About Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company …
Insider Activity of Entrada Therapeutics, Inc.
Over the last 12 months, insiders at Entrada Therapeutics, Inc. have bought $641,939 and sold $4M worth of Entrada Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Entrada Therapeutics, Inc. have bought $24.62M and sold $3.29M worth of stock each year.
Highest buying activity among insiders over the last 12 months: KIM PETER S (director) — $1.28M.
The last purchase of 25,000 shares for transaction amount of $364,673 was made by KIM PETER S (director) on 2024‑05‑14.
List of Insider Buy and Sell Transactions, Entrada Therapeutics, Inc.
| 2024-12-11 | Sale | 10 percent owner | 21,787 0.0592% | $20.23 | $440,751 | -10.38% | ||
| 2024-12-11 | Sale | 10 percent owner | 21,787 0.0592% | $20.23 | $440,751 | -10.38% | ||
| 2024-12-10 | Sale | 10 percent owner | 22,935 0.0623% | $20.77 | $476,360 | -12.19% | ||
| 2024-12-10 | Sale | 10 percent owner | 22,935 0.0623% | $20.77 | $476,360 | -12.19% | ||
| 2024-12-03 | Sale | President, Research & Develop. | 11,703 0.0312% | $20.15 | $235,786 | -4.93% | ||
| 2024-12-02 | Sale | President, Research & Develop. | 4,088 0.0108% | $20.26 | $82,834 | -2.07% | ||
| 2024-12-02 | Sale | Chief Financial Officer | 5,000 0.0131% | $20.00 | $99,978 | -2.07% | ||
| 2024-11-29 | Sale | President, Research & Develop. | 100 0.0003% | $20.00 | $2,000 | +0.20% | ||
| 2024-11-29 | Sale | Chief Financial Officer | 1,000 0.0027% | $19.97 | $19,970 | +0.20% | ||
| 2024-11-13 | Sale | President, Research & Develop. | 2,700 0.0072% | $20.04 | $54,109 | -3.78% | ||
| 2024-11-11 | Sale | President, Research & Develop. | 1,409 0.0038% | $20.01 | $28,191 | -1.56% | ||
| 2024-11-11 | Sale | Chief Financial Officer | 8,637 0.0233% | $19.98 | $172,562 | -1.56% | ||
| 2024-11-06 | Sale | President, Research & Develop. | 12,299 0.0336% | $18.85 | $231,776 | +6.06% | ||
| 2024-11-05 | Sale | President, Research & Develop. | 5,171 0.0142% | $18.18 | $94,006 | 0.00% | ||
| 2024-11-04 | Sale | President, Research & Develop. | 749 0.002% | $18.02 | $13,498 | +10.19% | ||
| 2024-10-16 | Sale | President, Research & Develop. | 600 0.0018% | $18.00 | $10,800 | +6.06% | ||
| 2024-09-26 | Sale | President & COO | 847 0.0025% | $16.00 | $13,552 | 0.00% | ||
| 2024-09-09 | Sale | Chief Scientific Officer | 2,642 0.0071% | $15.09 | $39,862 | +17.30% | ||
| 2024-09-09 | Sale | President & COO | 1,904 0.0051% | $15.07 | $28,690 | +17.30% | ||
| 2024-09-09 | Sale | Chief Financial Officer | 3,195 0.0086% | $14.97 | $47,832 | +17.30% |
Insider Historical Profitability
| MPM BioVentures 2014, L.P. | 10 percent owner | 4381062 11.7078% | $17.56 | 1 | 2 | <0.0001% |
| MPM BIOVENTURES 2018, L.P. | 10 percent owner | 4381062 11.7078% | $17.56 | 1 | 2 | <0.0001% |
| KIM PETER S | director | 92412 0.247% | $17.56 | 11 | 0 | |
| BAKER BROS. ADVISORS LP | 10 percent owner | 4501658 12.0301% | $17.56 | 8 | 0 | +124.37% |
| Baker Bros. Advisors (GP) LLC | 4475208 11.9594% | $17.56 | 3 | 0 | +129.14% |
Institutional Investor Ownership
| Baker Bros Advisors LP | $68.95M | 13.16 | 4.87M | 0% | +$0 | 0.5 | |
| MPM Asset Management LLC | $62.71M | 11.97 | 4.43M | 0% | +$0 | 25.58 | |
| 5Am Venture Management Llc | $62.47M | 11.92 | 4.41M | 0% | +$0 | 4.19 | |
| T. Rowe Price | $39.02M | 7.45 | 2.75M | -8.52% | -$3.63M | 0.01 | |
| BlackRock | $21.06M | 4.02 | 1.49M | -1.09% | -$231,948.75 | <0.0001 |